Crescent Biopharma, Inc. · NASDAQ:CBIO
McNeill Jonathan sold 4,570 Crescent Biopharma, Inc. shares (Form 4)
Traded Sep 16 to Sep 18, 2026 · Filed Sep 18, 2026
From Sep 16 to Sep 18, 2026, McNeill Jonathan (President and COO) sold 4,570 Crescent Biopharma, Inc. shares at an average US$16.90 for US$77,235 under a trading plan, leaving 134,588 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 4,570 shares
- Price
- US$16.90 average (US$16.71 to US$17.90)
- Value
- US$77,235
- Holding after
- 134,588 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Ordinary Shares | Sale | 731 | US$17.90 | 138,427 | Direct |
| Sep 18, 2026 | Ordinary Shares | Sale | 3,839 | US$16.71 | 134,588 | Direct |
Source
Related
- Crescent Biopharma, Inc.
- McNeill Jonathan
- Crescent Biopharma, Inc. shareholders
- Form 4 · McNeill Jonathan · Jun 23, 2026
- Form 4 · Brumm Joshua T · Sep 18, 2026
- Form 4 · Lynch Ryan · Sep 18, 2026
- Form 4 · Pinkas Jan · Sep 18, 2026
- Form 4 · Im Ellie Eunkyung · Sep 18, 2026
- Form 4 · Scalzo Richard William · Sep 18, 2026